- Home
- NLSP vs MVBF Comparison
NLSP vs MVBF Comparison
Compare NLSP & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- MVBF
- Stock Information
- Founded
- NLSP 2015
- MVBF 1997
- Country
- NLSP Switzerland
- MVBF United States
- Employees
- NLSP N/A
- MVBF N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- NLSP Health Care
- MVBF Finance
- Exchange
- NLSP Nasdaq
- MVBF Nasdaq
- Market Cap
- NLSP 12.4M
- MVBF 278.3M
- IPO Year
- NLSP 2021
- MVBF N/A
- Fundamental
- Price
- NLSP $2.13
- MVBF $23.85
- Analyst Decision
- NLSP
- MVBF Buy
- Analyst Count
- NLSP 0
- MVBF 5
- Target Price
- NLSP N/A
- MVBF $25.40
- AVG Volume (30 Days)
- NLSP 268.4K
- MVBF 48.4K
- Earning Date
- NLSP 07-22-2025
- MVBF 07-28-2025
- Dividend Yield
- NLSP N/A
- MVBF 2.87%
- EPS Growth
- NLSP N/A
- MVBF N/A
- EPS
- NLSP N/A
- MVBF 1.46
- Revenue
- NLSP N/A
- MVBF $146,101,000.00
- Revenue This Year
- NLSP N/A
- MVBF N/A
- Revenue Next Year
- NLSP N/A
- MVBF $14.22
- P/E Ratio
- NLSP N/A
- MVBF $16.25
- Revenue Growth
- NLSP N/A
- MVBF N/A
- 52 Week Low
- NLSP $1.30
- MVBF $15.59
- 52 Week High
- NLSP $15.59
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- NLSP 43.58
- MVBF 79.48
- Support Level
- NLSP $2.20
- MVBF $22.85
- Resistance Level
- NLSP $2.33
- MVBF $23.63
- Average True Range (ATR)
- NLSP 0.25
- MVBF 0.50
- MACD
- NLSP -0.07
- MVBF 0.13
- Stochastic Oscillator
- NLSP 6.86
- MVBF 95.93
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.